Ohr Pharmaceutical Reports Financial Results for the Fiscal First Quarter of 2019
Stockholder vote on the proposed merger with NeuBase Therapeutics anticipated in the second calendar quarter of 2019 NEW YORK, Feb. […]
Stockholder vote on the proposed merger with NeuBase Therapeutics anticipated in the second calendar quarter of 2019 NEW YORK, Feb. […]
Southfield, Michigan, Feb. 14, 2019 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, […]
Net cash used in operating and investing activities was $22.5 million in the fourth quarter and $30.0 million for the […]
BURLINGTON, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), The Digital Engagement Company™, today announced financial […]
REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on […]
BOSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company focused on the development […]
HONG KONG, Feb. 15, 2019 (GLOBE NEWSWIRE) — Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company […]
Fourth quarter total revenue up 10% from a year ago to $91.1 million; FY 2018 total revenue up 9% from […]
TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) — iLOOKABOUT Corp. (TSXV:ILA) (“iLOOKABOUT” or “the Company”) today announced that it has retained […]
-Teleconference Scheduled for February 27, 2019, at 5:00 p.m. ET- -Company to Host Research and Development Day on February 26, […]